Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NDORMS has renewed its Athena SWAN Silver Award status in recognition of our commitment to advancing equality and excellence in employment and education practices.

Montage for Athena Swan banner

An Athena SWAN silver award means an institution has progressed in embedding the Athena principles within its culture whilst holding a significant record and achievement in addressing gender equality more broadly for the benefit of all staff and students.

“I am incredibly proud of our staff and students, whose enthusiasm and dedication to making NDORMS an excellent and happy workplace led to the renewal of our Athena SWAN Silver status”, says Head of Department Professor Andrew Carr.

NDORMS offers progressive flexible working and family-leave policies and is committed to promoting a diverse and inclusive culture for everyone. A reflection of our commitment, our staff and students enjoy working at NDORMS, with 90% recommending it as an excellent workplace.

NDORMS Equality and Diversity Advisor, Maria Granell-Moreno adds: “We are delighted to have our efforts to promoting and supporting gender equality in all its forms recognised with this Silver award. And we are excited to get to work on implementing our Athena action plan, continuing on our path to supporting all staff and students achieve their potential and, why not, dreams and aspirations, alongside a healthy work–life balance!”

The Athena SWAN Charter was established in 2005 to encourage and recognise commitment to advancing the careers of women in science, technology, engineering, maths and medicine (STEMM) employment in higher education and research.

In May 2015, the charter was expanded to recognise work undertaken in arts, humanities, social sciences, business and law (AHSSBL), and in professional and support roles, and for trans staff and students. The charter now recognises work undertaken to address gender equality more broadly, and not just barriers to progression that affect women.

Similar stories

£1.2M to improve diagnosis of emergency spinal condition

The National Institute for Health and Care Research has awarded an Advanced Fellowship to Dr David Metcalfe to study the diagnosis of the spinal condition, cauda equina syndrome.

Professor Chris Lavy appointed to WHO technical advisory group

Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Gene variant links trigger finger and carpal tunnel syndrome

A new NDORMS study, published in The Lancet Rheumatology, has found a genetic variant that increases the risk of both carpal tunnel syndrome and trigger finger, and opens the door for new therapies that involve blocking the IGF-1 pathway.

Kennedy programmes support early career researchers

Since 2013 the Kennedy Institute of Rheumatology has been running a Career Development Programme, a scheme to help early career researchers launch their own independent laboratories, and more recently the Innovator Investigator Programme to bring new technologies to core research themes.

OCTRU collaboration boosts understanding of COVID vaccine response

Working with researchers across multiple universities, the Oxford Clinical Trials Unit (OCTRU) played a key role in delivering results of the national VROOM trial (Vaccine Response On Off Methotrexate).